Potential Medicare Part D Savings on Ophthalmic Generic Drugs

被引：3
|
作者：
Collet, David A. [1 ]
Urban, Matthew B. [1 ]
Amin, Abha [2 ]
机构：
[1] New York Med Coll, Sch Med, 40 Sunshine Cottage Rd, Valhalla, NY 10595 USA
[2] Westchester Med Ctr, Dept Ophthalmol, Valhalla, NY USA
来源：
JAMA OPHTHALMOLOGY | 2024年 / 142卷 / 07期
关键词：
D O I：
10.1001/jamaophthalmol.2024.1717
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
This economic evaluation assesses potential Medicare Part D savings on ophthalmic generic drugs if discount coupon prices are used.
引用
收藏
页码：678 / 680
页数：3
相关论文
共 50 条
  • [31] MEDICARE PART D ENROLLEES' USE OF OUT-OF-PLAN DISCOUNTED GENERIC DRUGS, REVISITED RESPONSE
    Stuart, Bruce
    Loh, F. Ellen
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2013, 61 (02) : 310 - 310
  • [32] Patient and Payer Incentives to Use Patented Brand-Name Drugs vs Authorized Generic Drugs in Medicare Part D
    Dusetzina, Stacie B.
    Sarpatwari, Ameet
    Carrier, Michael A.
    Hansen, Richard A.
    Keating, Nancy L.
    Huskamp, Haiden A.
    JAMA INTERNAL MEDICINE, 2021, 181 (12) : 1605 - 1611
  • [33] MEDICARE PART D, GENERIC PRESCRIBING AND ADHERENCE TO ANTIDEPRESSANT THERAPY
    Bao, Y.
    Ryan, A. M.
    Shao, H.
    Pincus, H. A.
    Donohue, J. M.
    EUROPEAN PSYCHIATRY, 2012, 27
  • [34] Relief in Sight - Estimated Savings under Medicare Part D Redesign
    Dusetzina, Stacie B.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (26): : E93 - E93
  • [35] Coverage and out-of-pocket spending on brand versus generic/biosimilar specialty drugs in Medicare part D
    Dusetzina, Stacie B.
    Jazowski, Shelley A.
    Cole, Ashley L.
    Nguyen, Joehl
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 311 - 312
  • [36] Coverage for Hepatitis C Drugs in Medicare Part D
    Jung, Jeah Kyoungrae
    Feldman, Roger
    Cheong, Chelim
    Du, Ping
    Leslie, Douglas
    AMERICAN JOURNAL OF MANAGED CARE, 2016, 22 (06): : SP220 - SP226
  • [37] Potential Savings Associated with Drug Substitution in Medicare Part D: The Translating Research into Action for Diabetes (TRIAD) Study
    Duru, O. Kenrik
    Ettner, Susan L.
    Turk, Norman
    Mangione, Carol M.
    Brown, Arleen F.
    Fu, Jeffery
    Simien, Leslie
    Tseng, Chien-Wen
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2014, 29 (01) : 230 - 236
  • [38] Potential Savings Associated with Drug Substitution in Medicare Part D: The Translating Research into Action for Diabetes (TRIAD) Study
    O. Kenrik Duru
    Susan L. Ettner
    Norman Turk
    Carol M. Mangione
    Arleen F. Brown
    Jeffery Fu
    Leslie Simien
    Chien-Wen Tseng
    Journal of General Internal Medicine, 2014, 29 : 230 - 236
  • [39] Medicare Part D Payments for Generic Imatinib From 2017 to 2023
    Dusetzina, Stacie B.
    JAMA INTERNAL MEDICINE, 2024, 184 (01) : 104 - 105
  • [40] Needed Assumptions for Potential Savings From Greater Use of $4 Generic Drugs
    Huesch, Marco D.
    ARCHIVES OF INTERNAL MEDICINE, 2011, 171 (17) : 1594 - 1595
12345